跳至主要内容
临床试验/ACTRN12621000709842
ACTRN12621000709842已完成3 期

Effect of topical and oral Resveratrol on skin health, condition and visible signs of ageing, in healthy ageing females.

RDC Clinical Pty Ltd0 个研究点目标入组 136 人开始时间: 2021年6月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
Female

入选标准

  • Females aged 40 years and above
  • Otherwise healthy
  • Agree not to change standard skincare routine
  • Able to provide informed consent
  • Agree not to undertake another clinical trial while enrolled in this trial

排除标准

  • Clinically significant medical conditions including, but not limited to, cardiovascular, neurological, psychiatric, renal, gastrointestinal, immunological, endocrine (including uncontrolled diabetes or thyroid disease) or haematological abnormalities that are uncontrolled
  • Currently taking resveratrol or using resveratrol cream
  • Cosmetic surgery and procedures, including Botox and other injectables, microdermabrasion, laser treatments
  • Active smokers, nicotine use, alcohol or drug (prescription or illegal substances) abuse
  • Chronic past and/or current alcohol use (Greater than 14 alcoholic drinks week)
  • Known pregnant or lactating woman
  • Allergies or hypersensitivity to resveratrol
  • Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion

研究者

相似试验